About the 2025 Event
The Only Industry Meeting Place for CAR & TCR Cell Therapy Development
As cell therapies continued to demonstrate transformative potential in the clinic whilst reaching new milestones for commercial success, the 10th CAR-TCR Summit returned as the world’s leading global forum to accelerate end-to-end development of cell therapies to patients in need.
Built by industry for industry, this year’s agenda featured end-to-end coverage of every stage of cell therapy development. From breakthroughs in novel engineering and armoring technologies, streamlined manufacturing to meet tight timelines, optimizing pre-clinical models to reviewing clinical data, to efficiently characterizing your cell therapy product.
Whether you were a C-level strategic leader, or analytical scientist, you were guaranteed to leave with actionable solutions to combat the contemporary challenges halting your therapeutic development. Cell therapy summit
The cell therapy community is stronger together. That's why at the 10th CAR-TCR Summit, you seized your opportunity to come together in an industry-focused environment to celebrate a decade of engineering a disease-free world, and solidify your impact on the future of cell therapy development in pursuit of the shared mission of bringing more life-saving therapies to patients in need. CAR-TCR Summit
Why the CAR-TCR Summit was a Must-Attend?
This was the blueprint industry meeting for cell therapy developers. Uniting academic KOLs, biopharma decision makers, pharma partnering leads, front-line scientists, and leading service providers to collaboratively address shared challenges and celebrate advances
Exploring the future potential of cell therapy with deep dives into solid tumors, automation, and the fundamentals of development and partnerships
You gained competitive insight across multiple scopes of indications from oncology to autoimmune to cover the growing trial expansion and ensure you stay ahead of the curve
It was more than just CAR & TCR content… this meeting covered the full range of cell types, including NK cells, Gamma Delta cells, Macrophages, TILs, and more to provide holistic coverage of cutting-edge scientific advancement in cell therapy
Cutting-Edge Scientific Content Catering to all Stages of Development:
Discovery & Translation
Advancing next-gen cell therapies through optimized translational development to gain regulatory approval and unlock broader indication potential.
Meet Discovery, pre-clinical and R&D innovators, translational, pharmacology and biomarker developmental teams
Clinical Development
Demonstrate safety, efficacy and durability across multiple cell types and indications to ensure clinical success.
Meet VPs and Heads of Clinical Development, Clinical Trial Leads and Heads of Regulatory Development
Early-Stage Manufacturing
Optimize process development and validation to establish robust platforms.
Meet CTOs, Heads of Process Development and Scientists focused on pre-clinical and early clinical manufacturing
Late-Stage Manufacturing
Master manufacturing process and overcome high costs to streamline manufacturing.
Meet CTOs, Global Heads of Manufacturing and MSAT Scientists
Analytical Development
Develop robust assays, optimize quality control and master varying instruments.
Meet VPs of Quality Control, Heads of Assay Developments and Scientists focusing on Analytical Development
Networking with Experts from the Full Cell Therapy Landscape
“I’m looking forward to hearing from other biotech companies the progress that has been made over the past year on various fronts from research to manufacturing to clinical and beyond.”
Legend Biotech, 2025 Speaker
Connect With Us to Stay Up to Date with the Field!
Join Our Twitter Following:
Join the LinkedIn Community:
